Autopsy report · NCT03784963

Efficacy of Omega-3 Fatty Acid Therapy in Preventing Gastrointestinal Bleeding in Patients With CF-LVAD

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Low enrollment”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 1 year 6 months before it stopped.
35 participants enrolled.
Results were posted on the registry 1 year after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: University of Chicago
Sponsor type: University, hospital or other
Conditions: Heart Failure; Gastrointestinal Bleeding
Interventions: Omega 3 fatty acids; Placebo
Participants: 35
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.